SCHEMBL27361558

SCHEMBL27361558

CC(C)n1c(=O)c(Cl)cc2cnc([S+]=O)nc21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.36
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
EGFR P00533 3/20 0.34
SRC P12931 2/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34
FGFR3 P22607 1/20 0.34
AURKA O14965 1/20 0.33
LIMK1 P53667 1/20 0.33
AURKB Q96GD4 1/20 0.33
MAPK8 P45983 6/20 0.32
MAPK10 P53779 4/20 0.32
MAPK9 P45984 2/20 0.32
GRM4 Q14833 3/20 0.32
PIK3CA P42336 2/20 0.32
MTOR P42345 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31637504 0.80 KMT2A (0.40) FGFR1CDK4CCND1CCND2CCND3
SCHEMBL27362189 0.80 KMT2A (0.40) FGFR1CDK4CCND1CCND2CCND3
SCHEMBL25123264 0.78 CCNE1 (0.36) CDK4CCND1CCND3
SCHEMBL29991028 0.78 CCNE1 (0.36) CDK4CCND1CCND3
SCHEMBL29991131 0.77 CYP1A2 (0.37) FGFR1GRM4PIK3CA
SCHEMBL27361790 0.72 PSEN1 (0.45) FGFR1CDK4CCND1CCND2CCND3
SCHEMBL27229130 0.72 BTK (0.37) FGFR1SRCGRM4
SCHEMBL27361409 0.71 CCND1 (0.54) FGFR1CDK4CCND1CCND2CCND3
SCHEMBL27166404 0.71 WEE1 (0.47) FGFR1CDK4CCND1CCND2CCND3
SCHEMBL29991471 0.70 MAPK8 (0.68) FGFR1CDK4CCND1CCND3MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039903-A2 CDK2 INHIBITORS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-02-22 WO disclosed